Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of The American Academy of Dermatology"
DOI: 10.1016/j.jaad.2019.09.035
Abstract: Background There are no specific recommendations for [18F] fludeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in assessing recurrent cutaneous squamous cell carcinoma (cSCC). Objective To evaluate FDG-PET/CT in recurrent cSCC. Methods FDG-PET/CT scans were retrospectively reviewed.…
read more here.
Keywords:
18f fludeoxyglucose;
recurrent;
fdg pet;
tomography ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Circulation"
DOI: 10.1161/circ.152.suppl_3.4370214
Abstract: Background: Atrial fibrillation (AF) is marked by underlying inflammation and metabolic changes. Atrial 18F-Fludeoxyglucose (FDG) positron emission tomography (PET) can be used to assess these changes. Previous studies show increased FDG avidity in AF. Aim:…
read more here.
Keywords:
fdg;
atrial 18f;
18f fludeoxyglucose;
avidity ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Alzheimer's Disease"
DOI: 10.3233/jad-170582
Abstract: Flutemetamol (18F-Flut) is an [18F]-labelled amyloid PET tracer with increasing availability. The main objectives of this study were to investigate 1) cerebrospinal fluid (CSF) Aβ 1-42 (Aβ42) concentrations associated with regional 18F-Flut uptake, 2) associations…
read more here.
Keywords:
pet;
pathology;
18f fludeoxyglucose;
18f flut ... See more keywords